Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000531645 | SCV000631418 | benign | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000083640 | SCV001942014 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31942420) |
Molecular Genetics, |
RCV000531645 | SCV004812687 | benign | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2023-05-04 | criteria provided, single submitter | clinical testing | European Non-Finnish population allele frequency is 3.124%% (rs9282858, 3075/152258 alleles, 43 homozygotes in gnomAD v3.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.5.1, this variant is classified as BENIGN. Following criteria are met: BA1 |
Breakthrough Genomics, |
RCV000083640 | SCV005241786 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000003511 | SCV000023669 | benign | STEROID 5-ALPHA-REDUCTASE POLYMORPHISM | 2008-08-15 | no assertion criteria provided | literature only | |
University of Sydney Medical Foundation | RCV000083640 | SCV000115726 | not provided | not provided | no assertion provided | not provided | ||
Clinical Molecular Genetics Laboratory, |
RCV000531645 | SCV000692378 | pathogenic | 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency | 2011-05-23 | no assertion criteria provided | clinical testing |